BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+0.82%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$22.8B
AUM Growth
+$22.8B
Cap. Flow
+$265M
Cap. Flow %
1.16%
Top 10 Hldgs %
82.65%
Holding
132
New
12
Increased
20
Reduced
6
Closed
10

Top Buys

1
ASND icon
Ascendis Pharma
ASND
$160M
2
PACB icon
Pacific Biosciences
PACB
$57.3M
3
KOD icon
Kodiak Sciences
KOD
$52.2M
4
TVTX icon
Travere Therapeutics
TVTX
$44.9M
5
BLUE
bluebird bio
BLUE
$43.4M

Top Sells

1
APLS icon
Apellis Pharmaceuticals
APLS
$144M
2
ADCT icon
ADC Therapeutics
ADCT
$34.5M
3
AMRN
Amarin Corp
AMRN
$23.4M
4
PTGX icon
Protagonist Therapeutics
PTGX
$20.4M
5
AUPH icon
Aurinia Pharmaceuticals
AUPH
$13.3M

Sector Composition

1 Healthcare 97.89%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EWTX icon
76
Edgewise Therapeutics
EWTX
$1.54B
$8.3M 0.04%
500,000
– –
CABA icon
77
Cabaletta Bio
CABA
$144M
$8.05M 0.04%
662,063
+25,700
+4% +$313K
CBAY
78
DELISTED
Cymabay Therapeutics
CBAY
$7.92M 0.03%
2,170,464
– –
ATHA icon
79
Athira Pharma
ATHA
$15.5M
$7.56M 0.03%
806,367
– –
GTH
80
DELISTED
Genetron Holdings Limited ADS
GTH
$6.31M 0.03%
151,769
– –
BMEA icon
81
Biomea Fusion
BMEA
$114M
$6.28M 0.03%
524,617
+230,500
+78% +$2.76M
AMYT
82
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$6.24M 0.03%
+518,380
New +$6.24M
NGM
83
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$6.13M 0.03%
291,801
– –
RVMD icon
84
Revolution Medicines
RVMD
$7.43B
$6.11M 0.03%
222,222
– –
KURA icon
85
Kura Oncology
KURA
$732M
$5.7M 0.03%
+304,158
New +$5.7M
ATYR
86
aTyr Pharma
ATYR
$560M
$5.68M 0.02%
+625,000
New +$5.68M
ALEC icon
87
Alector
ALEC
$282M
$5.46M 0.02%
239,228
– –
RLMD icon
88
Relmada Therapeutics
RLMD
$48.8M
$5.27M 0.02%
200,996
+124,396
+162% +$3.26M
CCXI
89
DELISTED
ChemoCentryx, Inc.
CCXI
$5.15M 0.02%
+301,195
New +$5.15M
TCDA
90
DELISTED
Tricida, Inc. Common Stock
TCDA
$4.81M 0.02%
1,037,432
+308,132
+42% +$1.43M
HRMY icon
91
Harmony Biosciences
HRMY
$2.16B
$4.74M 0.02%
123,600
– –
REPL icon
92
Replimune Group
REPL
$460M
$4.55M 0.02%
153,512
– –
DNLI icon
93
Denali Therapeutics
DNLI
$2.24B
$4.48M 0.02%
88,738
– –
NEXI
94
DELISTED
NexImmune, Inc. Common Stock
NEXI
$4.45M 0.02%
11,765
– –
HOOK
95
DELISTED
HOOKIPA Pharma
HOOK
$4.13M 0.02%
70,048
– –
ITOS
96
DELISTED
iTeos Therapeutics
ITOS
$4.06M 0.02%
150,346
– –
VINC
97
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$3.9M 0.02%
+12,069
New +$3.9M
XLRN
98
DELISTED
Acceleron Pharma Inc.
XLRN
$3.86M 0.02%
22,430
– –
BNR
99
Burning Rock Biotech
BNR
$85.6M
$3.74M 0.02%
20,913
– –
AKRO icon
100
Akero Therapeutics
AKRO
$3.65B
$2.65M 0.01%
118,378
– –
2 3
4
5 6